Industrialized GMP Production of CD34(+) Cells (ProtheraCytes®) at Clinical Scale for Treatment of Ischemic Cardiac Diseases Is Feasible and Safe

por Hénon, Philippe, Kowalczyk, Marc, Aries, Anne, Vignon, Christine, Trébuchet, Guillaume, Lahlil, Rachid
Publicado 2022